Thermo Fisher Scientific Inc.
$521.21
▼
-0.54%
2026-04-22 10:12:13
www.thermofisher.com
NYQ: TMO
Explore Thermo Fisher Scientific Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$194.29 B
Current Price
$521.21
52W High / Low
$643.99 / $385.46
Stock P/E
29.42
Book Value
$141.96
Dividend Yield
0.36%
ROCE
8.52%
ROE
13.02%
Face Value
—
EPS
$17.74
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
125,000
Beta
0.97
Debt / Equity
77.25
Current Ratio
1.89
Quick Ratio
1.53
Forward P/E
18.23
Price / Sales
4.14
Enterprise Value
$215.68 B
EV / EBITDA
19.36
EV / Revenue
4.84
Rating
Strong Buy
Target Price
$658.4
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Quest Diagnostics Incorporated | $200.41 | 22.15 | $22.16 B | 1.76% | 11.16% | 14.75% | $213.5 / $160.02 | $65.18 |
| 2. | bioAffinity Technologies, Inc. | $2.69 | — | $12.87 M | — | -131.93% | -3.02% | $17.44 / $0.69 | $1.62 |
| 3. | Check-Cap Ltd. | $1.9 | — | $13.56 M | — | 659.83% | -1.3% | $3.92 / $0.59 | $0.64 |
| 4. | Guardant Health, Inc. | $90.8 | — | $11.97 B | — | -25.56% | 348.42% | $120.74 / $36.36 | $-0.76 |
| 5. | Mainz Biomed N.V. | $0.47 | — | $5.89 M | — | -252.7% | -4.88% | $4.43 / $0.4 | $0.62 |
| 6. | GRAIL, Inc. | $51.2 | — | $2.1 B | — | -18.79% | -16.07% | $118.84 / $25.56 | $63.92 |
| 7. | Veracyte, Inc. | $33.45 | 39.66 | $2.63 B | — | 5.82% | 5.34% | $50.71 / $22.61 | $16.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 12.21 B | 11.12 B | 10.85 B | 10.36 B | 11.39 B |
| Operating Profit | 2.3 B | 2.08 B | 1.92 B | 1.81 B | 2.25 B |
| Net Profit | 1.96 B | 1.62 B | 1.62 B | 1.51 B | 1.83 B |
| EPS in Rs | 5.28 | 4.35 | 4.35 | 4.06 | 4.92 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 44.56 B | 42.88 B | 42.86 B | 44.91 B |
| Operating Profit | 8.11 B | 7.72 B | 7.32 B | 8.51 B |
| Net Profit | 6.7 B | 6.33 B | 6 B | 6.95 B |
| EPS in Rs | 18.04 | 17.05 | 16.13 | 18.7 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 110.34 B | 97.32 B | 98.73 B | 97.15 B |
| Total Liabilities | 56.81 B | 47.65 B | 51.88 B | 53.01 B |
| Equity | 53.41 B | 49.59 B | 46.73 B | 43.98 B |
| Current Assets | 28.71 B | 22.14 B | 24.59 B | 25.23 B |
| Current Liabilities | 15.19 B | 13.33 B | 14.01 B | 17.01 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 7.82 B | 8.67 B | 8.41 B | 9.15 B |
| Investing CF | -4.05 B | -5.84 B | -5.14 B | -2.16 B |
| Financing CF | 1.8 B | -6.79 B | -3.62 B | -2.81 B |
| Free CF | 6.29 B | 7.27 B | 6.93 B | 6.91 B |
| Capex | -1.52 B | -1.4 B | -1.48 B | -2.24 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 3.91% | 0.05% | -4.58% | — |
| Earnings Growth % | 5.82% | 5.67% | -13.74% | — |
| Profit Margin % | 15.05% | 14.77% | 13.99% | 15.47% |
| Operating Margin % | 18.2% | 18% | 17.08% | 18.94% |
| Gross Margin % | 40.93% | 41.28% | 39.9% | 42.24% |
| EBITDA Margin % | 25.83% | 26.9% | 25.85% | 26.59% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-13 | $0.47 |
| 2025-12-15 | $0.43 |
| 2025-09-15 | $0.43 |
| 2025-06-13 | $0.43 |
| 2025-03-14 | $0.43 |
Stock Splits
No stock split history available.